20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

Mission & History

Mission Statement

To advance St.Louis’ regional prosperity by cultivating a thriving biosciences sector. BioGenerator pursues this mission by building and investing in a robust pipeline of successful bioscience companies and entrepreneurs.

History

October 29, 2002

The “St. Louis Life Sciences Development Center” is incorporated by the Coalition for Plant and Life Sciences (later renamed BioSTL), as part of a comprehensive regional strategy for strengthening St. Louis’ bioscience innovation and entrepreneurship ecosystem. The Coalition for Plant and Life Sciences, founded and led by Dr. William Danforth, Chancellor Emeritus of Washington University in St. Louis, is comprised of the region’s top university, business, civic and philanthropic leaders, committed to establishing the infrastructure to capitalize on St. Louis’ unique strengths in medical and plant biosciences.

November 2003

St. Louis Life Sciences Development Center renamed “BioGenerator.”

March 2004

1st investment.

2009

BioGenerator moves to CIC@CET.

2009

BioGenerator hires new leadership team of Eric Gulve, President, Dan Broderick and Charlie Bolten, Vice Presidents

2010

Launch of Pre-Seed Fund.

May 2010

10th Investment.

October 2010

BioGenerator launches the BioGenerator Labs in the Cortex-1 building.

December 2010

BioGenerator secures 1 of 6 national Challenge awards from U.S. Dept. of Commerce, the National Institutes of Health, and the National Science Foundation designed to reward the most innovative ideas to drive technology commercialization and entrepreneurship in regions. BioGenerator led execution of the program, which launched 13 new companies.

July 2011

20th Investment.

September 2011

BioGenerator’s founding organization, the Coalition for Plant and Life Sciences, is reorganized under the name “BioSTL.” Multi-year financial commitments to BioSTL are announced by Washington University in St. Louis, BJC HealthCare, and St. Louis Life Science Project (an entity supported by St. Louis philanthropists Dr. William Danforth and John McDonnell).

October 2011

BioGenerator expands its Entrepreneur in Residence (EIR) program with an award from the U.S. Dept. of Commerce’s Jobs & Innovation Accelerator Challenge.

November 2011

BioGenerator reorganized as subsidiary of BioSTL, its funding organization.

December 2012

Galera Therapeutics, previously launched with seed funding by BioGenerator, announces $11 million Series A financing.

December 2012

BioGenerator portfolio companies cross the $100 million mark in additional, private investments attracted.

January 2013

BioGenerator investment moves Agtech startup Benson Hill to St. Louis.

2013

Launch of Post-Seed Fund.

March 2013

BioGenerator investment moves Adarza BioSystems to St. Louis.

Fall 2013

BioGenerator expands Labs facility to triple its size.

2014

BioGenerator completes its 50th investment.

April 2014

BioGenerator portfolio company Kogent Surgical announces Worldwide Distribution Agreement with Medtronic Surgical Technologies.

July 2014

BioGenerator launches Agtech startup Arvegenix with Pre-Seed funding.

2015

BioGenerator portfolio companies cross the $300 million mark in additional, private investments attracted.

March 2015

BioGenerator launches YourBevCo, a beverage device company.

March 2015

Cardialen, previously launched with BioGenerator seed funding, announces Series A financing and clinical development plans

March 2015

BioGenerator portfolio company Apse announces seed financing and appointment of new CEO.

July 2015

BioGenerator leads initial funding round for Healthcare IT startup Epharmix.

July 2015

BioGenerator increases investment in Confluence Life Sciences to $900K.

August 2015

MediBeacon, previously launched with BioGenerator seed funding, announces $22.4 million Series A financing.

August 2015

BioGenerator portfolio company SynerZ Medical is acquired in a private transaction.

August 2015

David Smoller, founder of successful startups ProteoPlex, Genome Systems, and SAGE Labs, and David Christenson, co-founder of the successful startup LDM Group, join BioGenerator as an Entrepreneurs in Residence.

October 2015

BioGenerator is among the first 17 recipients, out of 240 applicants, of a $500,000 grant from the 2014 Regional Innovation Strategies program to create the St. Louis Regional Bioscience Proof of Concept Center.

December, 2015

BioGenerator pre-seed investment helps S4 Agtech establish US operations at St. Louis’ Helix Center.

2016

BioGenerator Fundamentals and Grants2Business programs formalized; industry veteran Harry Arader hired to direct new programs.

2016

BioGenerator portfolio companies cross the $400 million mark in additional, private investments attracted.

January 2016

Pulse Therapeutics, previously launched with BioGenerator seed funding, announces $10M financing.

January 2016

With investment from BioGenerator, Agtech startup Edison Agrosciences moves to St. Louis.

April, 2016

BioGenerator increases investment in Confluence Life Sciences to $1.4M, making the company BioGenerator’s largest cumulative investment.

August 2016

Tioma Therapeutics, previously launched with seed funding by BioGenerator and based on technology developed at Washington University in St. Louis, announces $86 million Series A financing.

September 2016

Former Co-Founder and President of SAGE Labs, Edward Weinstein, joins BioGenerator as an Entrepreneur in Residence.

November 2016

Galera Therapeutics, previously launched with BioGenerator seed funding, announces $57 million Series B financing.

December 2016

BioGenerator investment catalyzes newly formed Indalo Therapeutics.

December 2016

BioGenerator launches new research tools company Canopy Biosciences.

January 2017

Adarza BioSystems, previously recruited to St. Louis with a BioGenerator seed investment, announces $17M Series B financing.

March 2017

Benson Hill BioSystems announces $25M Series B financing. The company was recruited to St. Louis in 2013 with Seed financing led by BioGenerator.

August 2017

Previously launched with BioGenerator pre-seed investment and BioGenerator’s largest single investment at $1.4M in cumulative capital, Confluence Life Sciences acquired by Aclaris Therapeutics for up to $100M.

August 2017

BioGenerator Fundamentals and Grants programs support the formation of new companies SentiAR and Plastomics, which both announce initial financing rounds.

2017

BioGenerator Labs, a unique wet lab co-working resource, reaches milestone of 200th active client.

2017

BioGenerator Grants program reaches milestone with 35th pre-investment grant awarded. Notable companies that received BioGenerator Grants prior to funding from any other source include Canopy Biosciences, SentiAR, Kalocyte, Plastomics, Unleash Immuno Oncolytics, Precision Virologics, and DiSARM Therapeutics.

Getting Started

Entrepreneurs Investors